Share chart Euroapi S.A.
Extended chart
Simple chart
About
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the composition of drugs for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.
Цена ао |
2.75 |
Выручка |
0.9158 |
EBITDA |
0.0568 |
Число акций ао |
0.0942 млрд |
P/S |
1.73 |
P/BV |
1.53 |
EV/EBITDA |
1.48 |
Сайт |
https://www.euroapi.com/en
|
Валюта |
usd |
Sector |
Health Care |
Industry |
Pharmaceuticals |
Валюта отчета |
usd |
Change price per day: |
-11.39% (3.95) |
Change price per week: |
-11.39% (3.95) |
Change price per month: |
-11.39% (3.95) |
Change price per 3 month: |
+23.52% (2.8335) |
Change price per half year: |
+17.06% (2.99) |
Change price per year: |
-39.66% (5.8) |
Change price per year to date: |
-34.87% (5.374) |
|
Underestimation
Title |
Value |
Grade |
P/S |
0.4742 |
10 |
P/BV |
0.5179 |
10 |
P/E |
0 |
0 |
EV/EBITDA |
8.07 |
8 |
Total: |
|
7.25 |
|
Efficiency
Title |
Value |
Grade |
ROA, % |
-11.77 |
0 |
ROE, % |
-20.45 |
0 |
Total: |
|
0.6667 |
|
|
Dividends
Title |
Value |
Grade |
Div yield, % |
0 |
0 |
DSI |
0 |
0 |
Total: |
|
0.5757 |
|
Debt
Title |
Value |
Grade |
Debt/EBITDA |
2.71 |
5 |
Total: |
|
8.2 |
|
Growth impulse
Title |
Value |
Grade |
Yield Revenue, % |
14.43 |
3 |
Yield Ebitda, % |
51.55 |
7 |
Yield EPS, % |
-7935.8 |
0 |
Total: |
|
4 |
|
Head |
Job title |
Payment |
Year of birth |
Mr. David Seignolle |
Chief Operating Officer |
N/A |
|
Mr. Kai Rossen |
Chief Scientific Officer |
N/A |
|
Ms. Marion Santin |
Chief Legal, Compliance, & IP Officer |
N/A |
|
Ms. Cecile Maupas |
Chief CDMO (Contract Development and Manufacturing Organization) Officer |
N/A |
|
Mr. Vincent Touraille |
Chief Strategy and M&A Officer |
N/A |
1963 (61 year) |
Sophie Palliez |
Head of Investor Relations |
N/A |
|
Mr. Ludwig De Mot |
CEO, Executive VP & Chief Transformation Officer |
N/A |
1963 (61 year) |
Ute Herzog |
Chief Human Resources Officer |
N/A |
|
Ms. Evelyne Nguyen |
Chief Financial Officer |
N/A |
1962 (62 years) |
Mr. Bruno Laforge |
Chief Corporate Affairs Officer |
|
|